CTOs on the Move

Pointe Scientific

www.pointescientific.com

 
Pointe Scientific Inc. is a Canton, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Medavie EMS

Medavie EMS is a health care delivery and management company based in Dartmouth, Nova Scotia, Canada.  We have a team of management staff that specializes in the areas of project management, planning, education, human resources, communications finance, physical resources, process design, facilitation, reporting, and information technology.   Currently, Medavie EMS is responsible to deliver EMS in Nova Scotia, New Brunswick, Prince Edward Island, the District Municipality of Muskoka in Ontario, the Municipality of Chatham-Kent in Ontario, Elgin County in Ontario, Saskatoon and surrounding areas in Saskatchewan, as well as, communities across eastern Alberta.  Each of these systems is managed by subsidiary companies which have established contracts with governments (provincial and municipal) or health authorities.   In addition, Medavie EMS operates a patient transfer service in Massachusetts headquartered in Boston.  Combined these companies directly employ or manage a total staff of approximately 3800, 550 of whom are in the US.

HemaCare Corporation

HemaCare Corporation is a Van Nuys, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Encoda

Our revolutionary technology is radically different than any other form of automated medical billing software or revenue cycle management. Unlike a PMS vendor or a clearinghouse, the Encoda BackOffice suite of products enhances and improves existing billing systems and billing service providers’ operations, making them more intelligent. The difference? On average, our customers increase staff productivity by more than 30% and dramatically reduce operating expenses, helping their practices to grow. How do we do this? We apply business intelligence and programming logic tools from the high-tech community to healthcare, and pass those technological advantages on to medical business offices. In adding this advanced technology to our clients’ systems, we create a direct connection between clients and payers, seamlessly integrating the two environments eliminating the need for human intervention.

Ohana Pacific

Ohana Pacific Health is a locally owned & operated health care management company in Hawaii. We treat everyone and each other like family.

Delphinus Medical Technologies

Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.